COGRX COG0201
Back to Drug Development Trials
![]()
Drug Development Trials
About the trial
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Study to Evaluate the Safety and Efficacy of CT1812 in Subjects With Mild to Moderate Alzheimer’s Disease.
